Prostatic Neoplasms
Showing NaN - NaN of 36
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Docetaxel, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Mobile, Alabama
- +214 more
Nov 24, 2022
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +2 more
-
Mobile, Alabama
- +257 more
Nov 22, 2022
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Fullerton, California
- +192 more
Oct 17, 2022
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Prostatic Tumors Trial in Toronto (stereotactic radiotherapy)
Active, not recruiting
- Prostatic Neoplasms
- stereotactic radiotherapy
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Mar 6, 2022
Prostatic Tumors Trial in Worldwide (Enzalutamide, NSAA, LHRHA or Surgical Castration)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +2 more
-
Boston, Massachusetts
- +81 more
Oct 7, 2021
Prostatic Tumors Trial in Toronto (Pre-treatment tumour oxygen measurements)
Active, not recruiting
- Prostatic Neoplasms
- Pre-treatment tumour oxygen measurements
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 4, 2021
Prostatic Tumors Trial in Toronto (hypoxia measurement)
Active, not recruiting
- Prostatic Neoplasms
- hypoxia measurement
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 1, 2021
Prostatic Tumors Trial in Toronto (Hyperpolarized Pyruvate (13C) Injection)
Withdrawn
- Prostatic Neoplasms
- Hyperpolarized Pyruvate (13C) Injection
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jan 20, 2020
Metastatic Cancer of Prostate: A Study of ZYTIGA Use in
Completed
- Prostatic Neoplasms
- Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
-
Calgary, Alberta, Canada
- +40 more
Dec 5, 2019
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
-
Scottsdale, Arizona
- +67 more
Jun 30, 2019
Prostatic Tumors, Prostate Cancer, Cancer of the Prostate Trial in Canada, United States (High-resolution ultrasound guided
Completed
- Prostatic Neoplasms
- +2 more
- High-resolution ultrasound guided prostate biopsy
- Standard ultrasound guided prostate biopsy
-
Baltimore, Maryland
- +4 more
Feb 6, 2019
Prostatic Tumors Trial in Abbotsford, Winnipeg, Toronto (Image-guided radiotherapy)
Unknown status
- Prostatic Neoplasms
- Image-guided radiotherapy
-
Abbotsford, British Columbia, Canada
- +2 more
Feb 15, 2019
Prostatic Tumors Trial in Toronto (Machine Learning Planning, Radiation Therapist Planning)
Completed
- Prostatic Neoplasms
- Machine Learning Planning
- Radiation Therapist Planning
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Sep 5, 2018
Prostatic Tumors Trial in Toronto (conformal intensity modulated radiotherapy (IMRT))
Completed
- Prostatic Neoplasms
- conformal intensity modulated radiotherapy (IMRT)
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Jun 8, 2018
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, mitoxantrone, prednisone)
Cancer of the Prostate, Prostate Cancer, Prostatic Tumors Trial in Toronto (Lycopene, Vitamin D3, Selenium, Green Tea Extract,
Completed
- Cancer of the Prostate
- +2 more
- Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E
- Placebo
-
Toronto, Ontario, CanadaUniversity Health Network - Princess Margaret Hospital
Feb 13, 2018
Cancer of the Prostate, Prostate Cancer, Prostatic Tumors Trial in Toronto (Lycopene, Vitamin D3, Selenium, Green Tea Extract,
Completed
- Cancer of the Prostate
- +2 more
- Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E
- Placebo
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 24, 2017
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (BAY88-8223))
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Brugge, Belgium
- +214 more
Mar 30, 2017
Prostatic Tumors Trial in Toronto (Erectile Dysfunction)
Completed
- Prostatic Neoplasms
- Erectile Dysfunction
-
Toronto, Ontario, CanadaUniversity Health Network Princess Margaret Hospital
Feb 8, 2016
Prostatic Tumors Trial in Toronto (daily Xray volume imaging for planning radiotherapy)
Completed
- Prostatic Neoplasms
- daily Xray volume imaging for planning radiotherapy
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Jul 15, 2015